Eris Lifesciences Limited, a leading Indian branded formulations company, today announced a breakthrough step in expanding access to advanced diabetes care with the launch of its generic Semaglutide under the brand SUNDAE in India
oral Wegovy 25 mg daily (new 2026 approval)
Benefits of microdosing semaglutide Lets get into the benefits of microdosing semaglutide: Significantly reduced gastrointestinal side effects Standard semaglutide doses have certain common side effects such as nausea, vomiting, bloating, abdominal pain, stomach ache, constipation, and diarrhea
Kruisselbrink R, Gharapetian A, Chaparro LE, Ami N, Richler D, Chan VWS, et al